I am a board-certified medical oncologist who works as part of a multidisciplinary team to treat patients with prostate cancer and other genitourinary malignancies. My primary focus is on the medical treatment of men with advanced or high-risk prostate cancer.
In addition to using standard therapies, I develop and design clinical trials testing new agents directed at androgen receptor signaling and other molecular pathways of disease progression.
I currently serve as an expert panel member on the American Society of Clinical Oncology (ASCO) Clinical Guidelines Committee and I am co-chair of the ASCO Genitourinary Guidelines Advisory Group. I am also an active participant in the Department of Defense Prostate Cancer Clinical Trials Consortium (PCCTC), an initiative designed to increase patient access to clinical trials across the country.